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Animal and clinical studies have demonstrated that oxidative stress, a common
pathophysiological factor in cardiac disease, reduces repolarization reserve by enhancing
the L-type calcium current, the late Na, and the Na-Ca exchanger, promoting early
afterdepolarizations (EADs) that can initiate ventricular tachycardia and ventricular
fibrillation (VT/VF) in structurally remodeled hearts. Increased ventricular fibrosis plays a
key facilitatory role in allowing oxidative-stress induced EADs to manifest as triggered
activity and VT/VF, since normal non-fibrotic hearts are resistant to arrhythmias when
challenged with similar or higher levels of oxidative stress. The findings imply that
antifibrotic therapy, in addition to therapies designed to suppress EAD formation at the
cellular level, may be synergistic in reducing the risk of sudden cardiac death.
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In a previous review, (Weiss et al., 2010) we discussed the ionic
basis of early afterdepolarizations (EADs) and summarized recent
theoretical and experimental evidence that the synchronization
of chaotic EAD dynamics provides both the trigger (rapid focal
activation) and the substrate (dispersion of repolarization) to
cause polymorphic ventricular tachycardia (PVT), torsade de
pointes (TdP), and ventricular fibrillation (VF) (Asano et al.,
1997; Choi et al., 2002; Xie et al., 2007, 2010; Sato et al., 2009,
2010). We emphasized that EADs and triggered activity occur
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depolarizations; VT/VF, ventricular tachycardia and ventricular fibrillation respec-
tively; PVT, polymorphic ventricular tachycardia; TdP, torsade de pointes; ICa-L,
L-type Ca current; PVC, premature ventricular complex; APD, action potential
duration; ROS, reactive oxygen species; H2O2, hydrogen peroxide; CV, conduc-
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phosphate; Ca2+-CaMK, calcium calmodulin-dependent kinase; INaK, electrogenic
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when the activation rate of the outward potassium (K) current
is sufficiently delayed in the window voltage range of L-type Ca
current (ICa-L) to allow ICa-L to recover from inactivation and
gain sufficient amplitude to evoke a propagated wavefront caus-
ing premature ventricular complex (PVC). In other words, the
time constants of Ca and K currents have to be in resonance
with each other for voltage oscillations underlying EADs to occur
(Chang et al., 2012a). The kinetic interdependency between these
currents explains the failure of EAD formation with agents that
prolong action potential duration (APD) outside the ICaL win-
dow current voltage range, preventing ICaL from gaining sufficient
amplitude to reverse repolarization (Xie et al., 2009; Weiss et al.,
2010; Madhvani et al., 2011). In this paper, we briefly review the
early work done on EADs and triggered activity, summarize the
state of knowledge on the dynamic and ionic basis of oxidative
stress-mediated initiation and termination of EAD-mediated trig-
gered activity, and discuss how myocardial structural remodeling
in the form of increased cardiac tissue fibrosis critically promotes
EAD-mediated VT/VF both in experimental and simulation stud-
ies. Finally, we discuss antifibrotic therapy as a potential strategy
to reduce sudden death in high risk patients with heart disease.
[Note: Triggered activity is also caused by delayed afterdepolar-
izations that arise after full action potential repolarization (Wit
and Cranefield, 1976; Cranefield, 1977). In this review we focus
exclusively on EADs].
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BRIEF HISTORICAL BACKGROUND OF EADs
The transition from a normal or slow to suddenly rapid elec-
trical activity in cardiac tissue has the potential to precipitate
lethal cardiac arrhythmias. An example is the sudden transi-
tion to a rapid repetitive activity by depolarizing afterpoten-
tials coined by Cranefield as “triggered activity” (Aronson and
Cranefield, 1974; Cranefield, 1975). Unlike automaticity, trig-
gered activity necessarily requires a prior action potential (AP)
to initiate repetitive activity (thus the term “triggered automatic-
ity” is a misnomer). One type of triggered activity arises from
EADs that interrupt repolarization and reverse dV/dt from neg-
ative to positive. This sort of electrical activity was first observed
in nerve cells where periods of rapid spiking, i.e., bursting, are
followed by quiescent, silent periods before another bursting
episode emerges (Connors and Gutnick, 1990). Based on these
observations Cranefield wrote: “I have suggested that in confor-
mity with the terminology used by neurophysiologist, this sort of
afterpotential be called an ‘early afterdepolarization’” (Cranefield,
1975, 1977). The defining feature of EADs is that they arises
during either phase 2 (January and Riddle, 1989) or phase 3
(Burashnikov and Antzelevitch, 2003; Maruyama et al., 2011) of
the AP before the membrane potential has fully repolarized to the
resting level.
It is likely that the phenomenon of EAD-mediated triggered
activity was already observed by Marcel Segers during the period
from 1939 to 1947 using unipolar extracellular recording electro-
grams in the pre-glass microelectrode recording period (Segers,
1939). His discovery of the association between “supernormal-
ity” and the “negative after-potential” on unipolar electrograms
(i.e., depolarizing potential) led him to describe triggered activity
this way: “Extrasystolic arrhythmias could develop under condi-
tions that augment the negative after-potential, such as an increase
in the extracellular calcium concentration, aconitine, veratrine,
adrenaline, and digitalis” (Segers, 1942). By using monopha-
sic AP recordings, Segers later showed the presence of “early
afterpotentials” and “delayed afterpotentials” which he called
potentiels tardifs (late potentials). He described the resulting
triggered activity as “battement auto-entretenu du coeur” (self-
sustained beating of the heart) (Segers, 1947). Right after the
introduction of glass microelectrode recording technique, Dawes
commented in an interesting 1952 review article: “The recent pub-
lication of methods of obtaining membrane action potentials from
single cardiac fibres . . .makes it highly desirable that these observa-
tions of Segers should be repeated on such preparations, in order
to obtain unequivocal records of these changes” (Dawes, 1952).
The technique of glass microelectrode recording was invented
by Ling and Gerard in 1949 to record action potentials from
frog skeletal muscle cells (Ling and Gerard, 1949) and in 1951
was adapted by Woodbury and associates for cardiac cell AP
recording (Woodbury et al., 1951). Perhaps the first cellular EAD
recordings with the glass microelectrode technique was made
by Coraboeuf (Coraboeuf and Boistel, 1953) in cardiac Purkinje
fibers in 1953. By exposing cardiac Purkinje fibers to elevated par-
tial pressure of carbon dioxide in the perfusion medium to induce
acidosis, Coraboeuf demonstrated the EAD-mediated triggered
activity shown in Figure 1A (Coraboeuf and Boistel, 1953). In
the terminology at the time, he described the observed EADs
and triggered activity as “humps,” “second upstroke,” and “reex-
citation,” or “repetitive activity” (Coraboeuf and Boistel, 1953).
In the ensuing years this potentially arrhythmogenic mecha-
nism was characterized using glass microelectrodes by multiple
laboratories, induced by diverse forms of stresses designed to
mimic various diseased cardiac conditions. The EAD-inducing
stresses included hypoxia by Trautwein et al. (1954) elevated
catecholamines by Hoffman and Cranefield (1960) aconitine by
Schmidt (1960) extracellular ion manipulation by Hutter and
Noble (1961) and reduction of delayed rectifier potassium current
(“repolarization reserve reduction”) by Hauswirth et al. (1969).
The importance of reduced repolarization reserve in promot-
ing EAD-mediated triggered activity was later directly tested by
Katzung who injected a small and steady constant depolariz-
ing currents in isolated papillary muscle which elicited rapid
repetitive activity that he called “regenerative discharge of action
potentials” or “depolarization-induced automaticity” (Katzung,
1975). The effect of premature stimulation on cesium-induced
EADs were investigated by Damiano et al. (Damiano and Rosen,
1984) and the influence of ICa-L agonists on EADs was assessed by
January et al. in short segments of cardiac Purkinje fibers using
voltage-clamp technique (January et al., 1988). These studies sug-
gested that EADs are more prone for termination by a premature
stimulus at more negative membrane potentials (Damiano and
Rosen, 1984) and the EAD arise as a result of reactivation of
ICa-L (January et al., 1988). More recently, reactive oxygen species
(ROS) produced either with hydrogen peroxide (H2O2) (Ward
and Giles, 1997; Song et al., 2006; Xie et al., 2009; Madhvani et al.,
2011; Nguyen et al., 2012) or angiotensin II (ATII) via the activa-
tion of the NADPH oxidase, (Xie et al., 2009; Bapat et al., 2012)
and mitogen-activated kinases (JNK, p38) (Bapat et al., 2012)
have been shown to potently induce EADs in isolated cardiac
myocytes.
DYNAMIC AND IONIC BASES OF EAD-MEDIATED
TRANSIENT TRIGGERED ACTIVITY
Non-linear dynamics has provided important insights into the
mechanisms of cardiac rhythm disorders. Bifurcation theory has
been particularly useful in defining and predicting the emer-
gence of cardiac instabilities such as electrical alternans and
EAD-mediated triggered activity. A bifurcation occurs when an
alteration in the value of one or more parameters in a sys-
tem causes a qualitatively new behavior to emerge. For example,
the phenomenon of APD alternans, caused by steep slope APD
restitution curve, (Nolasco and Dahlen, 1968) is an example of
bifurcation whereby a critical rise in the pacing rate (the bifur-
cation parameter) suddenly causes APD to alternate between
long and short values. The dynamic bifurcation sequence also
explains very complex and irregular cellular dynamics (chaos)
that arise at still faster rates of pacing (Guevara et al., 1981,
1984; Chialvo and Jalife, 1987; Chialvo et al., 1990; Karagueuzian
et al., 1993). The slope of the APD restitution curve (a plot
of APD vs. previous diastolic interval) regulates APD alternans
under diverse cardiac conditions, (Garfinkel et al., 2000) and
its magnitude has been used as a marker for electrical instabil-
ity causing dispersion of repolarization, wavebreak and VT/VF
(Karagueuzian et al., 1993; Garfinkel et al., 2000; Weiss et al.,
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FIGURE 1 | (A) Initiation of EAD-mediated triggered activity in canine
cardiac Purkinje fibers during acidosis (A) and hypokalemia (B). (A) The
numbers 1–4 indicate progressive increase in the duration (2, 5, 7,
8.5min) of acidosis (20% CO2 and 80% O2) as shown below each
recording [from Corabeuf, 1953 (Coraboeuf and Boistel, 1953)]. (B) Action
potentials in a canine cardiac Purkinje fiber exposed to hypokalemia
(K+0 = 2mmol/L) of increasing duration. Notice that the 3rd beat shows
four EAD-mediated action potentials. The 4th recording shows
EAD-mediated triggered activity that end with repolarization failure
(from Cranefield, 1977).
2006). Later studies further refined the APD restitution hypoth-
esis by incorporating the independent contribution made by
the intracellular Ca ([Ca+2i ]) dynamics and conduction veloc-
ity (CV) restitution in promoting APD alternans (Weiss et al.,
2006).
Recent dynamical analysis has revealed a bifurcation mech-
anism underlying EAD-mediated triggered activity in cardiac
tissue, namely dual Hopf-homoclinic bifurcations (Tran et al.,
2009; Chang et al., 2012a). In this scenario, the voltage oscil-
lations underlying EADs are generated by a Hopf bifurcation,
and are eventually terminated by a homoclinic bifurcation. A
Hopf bifurcation is a dynamical process by which an equilib-
rium (in this case, the plateau voltage) becomes unstable and
begins to oscillate, and is a common bifurcation to many phys-
ical and biological phenomena. For example, the collapse of
the Tacoma Narrows Bridge in 1940 was attributed to a Hopf
bifurcation. Initially the cause of the collapse was attributed
to an external periodic (oscillatory) force produced by the
wind. However, later analyses suggested that the mechanism
and the origin of the oscillations were actually the result of
the emergence of an unstable combination of air speed and
torsional stiffness of the bridge triggering self-induced oscil-
lations (via Hopf bifurcation) that eventually led to the col-
lapse of the bridge (Billah and Scanlan, 1991). In biological
systems, Hopf bifurcations have been proposed to underlie bio-
logical oscillation such as cell cycle, (Qu et al., 2003) pace-
making in neurons and heart, (Guevara and Jongsma, 1992)
glycolytic oscillations, (Goldbeter and Lefever, 1972), and circa-
dian rhythms (Goldbeter, 1995).
In the case of EADs, the requirements for voltage to oscillate
during phase 2 or phase 3 of the cardiac AP depend strongly on
the properties of ICa-L in relation to repolarizing outward cur-
rents. Oscillatory behavior emerges in the ICa, L window voltage
range (−40 to 0mV), where the steady state ICa-L activation and
inactivation curves overlap, but can occur only when the acti-
vation of time-dependent outward currents, particularly IKs, is
delayed as in the setting of reduced repolarization reserve (Tran
et al., 2009; Madhvani et al., 2011; Chang et al., 2012a). The
presence of Ca waves may act synergistically with ICa, L reactiva-
tion to promotes EADs (Volders et al., 2000; Zhao et al., 2012).
The Hopf bifurcation initiates the membrane oscillations, causing
single or multiple EADs. As the outward currents slowly acti-
vate, the system gradually approaches and passes the homoclinic
bifurcation, at which point the oscillations (EADs) are destroyed
and the AP fully repolarizes. The Hopf-homoclinic bifurcation
hypothesis of EAD formation was rigorously validated using a
three variable ventricular action potential cell model in which
the rate constants of activation and inactivation of the L-type Ca
current (ICa-L) and the rate constant of activation of the delayed
rectifier K current (IK) were varied. The Hopf-homoclinic bifur-
cation sequence required that the time constants of these currents
were properly matched (Tran et al., 2009; Chang et al., 2012a).
Briefly, EADs were produced when the activation rate of IK was
slow enough to allow the AP plateau voltage to drift gradually
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into the ICa-L window voltage range. In addition, the voltage
dependence of the ICa-L steady-state activation and the inactiva-
tion curves had to be steeply sloped (Tran et al., 2009; Sato et al.,
2010; Chang et al., 2012a). This scenario was reproduced exper-
imentally in isolated rabbit ventricular myocytes using a hybrid
biological–computational approach (dynamic clamp) to intro-
duce a virtual ICa-L with programmable properties into a patch-
clamped ventricular myocyte, such that the biophysical properties
of the virtual ICa-L could be manipulated at will (Madhvani et al.,
2011). More recently, we extended the computational analysis
to a more realistic cardiac cell model incorporating detailed Ca
cycling and ionic fluxes (Chang et al., 2012a). Under these con-
ditions, we found that long bursts of EAD-mediated triggered
activity could be induced, whose interspike frequency gradually
slowed before the burst terminated. The latter frequency-slowing
prior to burst termination feature is a classic dynamical signa-
ture of the Hopf-homoclinic bifurcation mechanism, previously
noted in bursting neurons, (Song and Xu, 2009) and agreed
with experimental observations in cultured neonatal rat ventric-
ular myocyte monolayers. In this case, EAD burst termination
was mediated by progressive intracellular Na accumulation dur-
ing the burst, which gradually increased repolarization reserve
by stimulating electrogenic Na-K pump outward current (INaK)
(Chang et al., 2012a). We confirmed this ionic mechanism of
termination of the triggered activity by clamping the intracellu-
lar Na in the cell model, which caused the bursting to continue
indefinitely.
An important prediction of the dual Hopf-homoclinic bifur-
cation mechanism is that EADs occur only over a critical range of
reduced repolarization reserve, and can be terminated by either
increasing or further decreasing repolarization reserve (Tran et al.,
2009; Chang et al., 2012a). The latter prediction was experimen-
tally tested in cardiac monolayers treated with BayK8644 and
isoproterenol to induce bursts of EAD-mediated triggered activ-
ity. Further reducing repolarization reserve by blocking the tran-
sient outward K current with 4-amino pyridine, or by blocking
the Ca2+-CaM-dependent inactivation of the ICa-L by overex-
pressing mutant Ca2+-insensitive calmodulin (CaM1234) further
prolonged APD but suppressed EAD-mediated triggered activity
(Chang et al., 2012a). These findings emphasize the importance
of the membrane voltage gradually entering the ICa-L window
voltage range for EADs to occur. If the membrane voltage dur-
ing the AP plateau remains above 0mV, EADs are unlikely to
occur, regardless of how long the APD is. This finding accounts
for previous observations that AP triangulation (where the AP
plateau gradually drifts below 0mV during repolarization) is
much more arrhythmogenic than APD prolongation in which
the AP maintains a high plateau voltage (Shah and Hondeghem,
2005; Hondeghem, 2008). Finally, when repolarization reserve
is reduced even further, repolarization failure occurs and the
membrane potential remains depolarized. Under these condi-
tions, small amplitude membrane oscillations can result from
intracellular Ca waves, which activate Ca-sensitive currents, such
as in isolated cardiac myocytes exposed to oxidative stress with
H2O2 and ATII and hypokalemia (Figure 1B) (Cranefield, 1977;
Bapat et al., 2012; Nguyen et al., 2012). Dynamically, repolar-
ization failure arises from a different type of bifurcation, called
saddle-node bifurcation which results in bistability (Chang et al.,
2012b).
OXIDATIVE STRESS, REPOLARIZATION RESERVE
REDUCTION, AND EADs
Mammalian cells utilize redox signaling via ROS such as H2O2
to regulate diverse physiological pathways including cell prolif-
eration, differentiation, and migration (Sundaresan et al., 1995;
Rhee, 2006). Due to the potential toxicity when ROS levels rise
excessively, H2O2 has been described as “a necessary evil for cell
signaling” (Rhee, 2006). Thus, the concept of redox signaling was
recognized not only by its regulatory role in normal physiolog-
ical processes but also by its influence on disease progression,
(Cave et al., 2006; Rhee, 2006) including its demonstrated abil-
ity to enhance cardiac vulnerability to arrhythmias in animal and
human studies (Corretti et al., 1991; Carnes et al., 2001; Lokuta
et al., 2005; Erickson et al., 2008; Morita et al., 2009; Erickson
et al., 2011). Oxidative stress reduces repolarization reserve by
enhancing late INa (INa-L), ICa-L, and the Na-Ca exchanger to
favor the formation of EADs (Corretti et al., 1991; Ward and
Giles, 1997; Song et al., 2006; Xie et al., 2009; Zhao et al., 2011).
Oxidative stress also inhibits glycolysis, (Corretti et al., 1991) a
major supplier of ATP to the sarcoplasmic-endoplasmic retic-
ulum Ca2+-activated ATPase (SERCA) pump (Xu et al., 1995;
Morita et al., 2011a) that reduces the SR Ca uptake further adding
to dysregulation of intracellular Ca cycling dynamics. Finally,
while other enzymatic pathways may also be activated by oxida-
tive stress such as xanthine oxidase causing afterpotentials like
hydrogen peroxide, (Goldhaber, 1996) the purpose of this review
however, is to exclusively focus on the enzymatic pathways shown
to induce afterpotentials and triggered activity causing VT/VF.
Recently, a major pathway by which oxidative stress has been
shown to increase ICa-L and late INa-L is via activation of Ca-
calmodulin dependent protein kinase II (CaMKII) (Ward and
Giles, 1997; Song et al., 2006; Erickson et al., 2008; Xie et al., 2009;
Zhao et al., 2011). H2O2-mediated activation of CaMKII occurs
by the oxidation of paired methionine residues (M281/282) in
the regulatory domain of CaMKII which removes the auto-
inhibition of the enzyme by freeing the catalytic site causing
sustained CaMKII activity even in the absence of Ca2+/CaM
(Erickson et al., 2008). CaMKII oxidation could be reversed by
methionine sulfoxide reductase A (MsrA) and MsrA knockout
mice show exaggerated CaMKII oxidation causing myocardial
apoptosis, impaired cardiac function, and an increased mortal-
ity after myocardial infarction (Erickson et al., 2008). Oxidative
stress is directly induced by ATII via the nicotinamide adenine
dinucleotide phosphate (NADPH) oxidase system, which, like
exogenous H2O2, leads to oxidative activation of CaMKII (Zhao
et al., 2011). Indeed, ATII (1–2μM) increases ROS fluorescence
in cardiac myocytes to promote EADs that could be abolished by
NADPH oxidase inhibitor, apocynin (Zhao et al., 2011). As in the
case of the H2O2, oxidative stress caused by ATII activates ICa-L
and INa-L causing reduced repolarization reserve and promotion
of EADs (Zhao et al., 2011). These results indicate that CaMKII
can integrate Ca2+ and ROS signaling to promote EADs in iso-
lated myocytes (Erickson et al., 2008; Xie et al., 2009; Zhao et al.,
2011).
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EADs AT THE ISOLATED MYOCYTE vs. INTACT TISSUE LEVEL
While oxidative stress caused by H2O2 and ATII readily initiate
EADs in isolated cardiac myocytes, (Ward and Giles, 1997; Song
et al., 2006; Xie et al., 2009; Zhao et al., 2011; Bapat et al., 2012;
Nguyen et al., 2012) an obvious question arises if these same stres-
sors also initiate EAD-mediated triggered activity in intact hearts.
We investigated this question in intact normal adult rat and rab-
bit hearts using isolated-perfused Langendorff preparations. We
found that both H2O2 and ATII, which readily promoted EADs
in single isolated myocytes, consistently failed to promote EADs
in intact hearts from normal young adult rats and rabbits even
when we raised the level of these two stressors beyond the level
that promoted EADs in the isolated myocytes (Morita et al., 2009,
2011a,b; Sato et al., 2009; Bapat et al., 2012). Since EADs typi-
cally occur irregularly, rather than consistently from beat-to-beat,
the discrepancy between isolated myocytes vs. intact normal heart
may result from the powerful source-sink relationship in well-
coupled cardiac tissue. That is, if a few EAD-generating cells (i.e.,
“source”) are well-coupled to many normally repolarizing cells
with no overt EADs (i.e., “sink”), the source-sink mismatch may
prevent the EADs from manifesting in tissue (Xie et al., 2010).
The importance of diffusive electrotonic cellular coupling on the
modulation of EADs is demonstrated by coupling two isolated
myocytes, one with EADs and the other without EAD, via a vari-
able resistor. With infinite resistance between the two cells (i.e.,
complete cellular uncoupling), the EADs readily appear in the cell
that produces EAD. However, when electrical coupling is applied
between the two cells, the amplitude of the EAD producing cell
starts to lose amplitude as the intercellular coupling conductance
between the two cells increases and with a sufficiently high cou-
pling conductance the EAD-producing cell no longer produces
EADs. Figure 2 illustrates the phenomenon of EAD suppression
in a cardiac myocyte by electrotonic coupling (Saiz et al., 1999;
Huelsing et al., 2000). Our simulation studies using a realistic
cardiac cell model in Three dimensional (3D) normally-coupled
tissue showed that one needs ≈700,000 contiguous cells that syn-
chronously produce EADs in order to overcome the source-sink
mismatch and allow a triggered PVC to propagate (Xie et al.,
2010). In two dimensional (2D) tissue this number decreases
to ≈7000, and in a 1D cable to ≈70. Interestingly and as expected,
FIGURE 2 | Suppression of EAD by coupling to a cell with no EAD (A)
and (B) and initiation of propagating EADs in 1D cable with a critical
number of cell synchronously firing EADS (C) and (D). (A) In the
uncoupled state (solid traces) the EAD is apparent, however, as the
coupling resistance between the EAD cell and the non-EAD cell with a
resting potential of −80mV is progressively reduced the amplitude of the
EAD decreases and eventually it is suppressed at coupling resistances
>500MW. (B) Intercellular current flow during coupling of the two cells
with decreasing resistances (dashed traces) shown in panel (A). The solid
trace shows zero current flow between the two cells in the uncoupled
state (from Huelsing et al., 2000). Panels (C) and (D) show AP traces
along a 1D cable, with the red traces indicating the EAD-susceptible cells
in the central region (middle diagram), and the normal non-susceptible
cells in black. The EAD failed to propagate with 69 susceptible cells in the
central region (C), but propagated successfully with 70 susceptible cells
(D) (from Xie et al., 2010).
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the minimum number of cells needed to produce a propagated
EAD-induced PVC in 3D tissue decreased by as large as 40 fold
when cell-to-cell gap junctional coupling is reduced (Xie et al.,
2010). Fibrosis, which imposes insulating collagen bands between
strands of myocytes (essentially converting 3D tissue into a net-
work of 1D cables), was evenmore potent at reducing the number
of myocytes required for PVC formation. Figure 2 illustrates
our methods of assessing the importance of cellular coupling in
the genesis of EAD in one dimensional (1D) cable (Xie et al.,
2010). These experimental and simulation studies strongly sug-
gest that the observed discrepancy in EAD production between
isolated myocytes and normally-coupled cardiac tissue may result
from the source-sink mismatch. In a well-coupled cardiac tissue,
the source-sink mismatch provides a powerful protective effect
to suppress EAD formation by the delinquent cells, preventing
the emergence of cardiac arrhythmias. Based on these findings,
it could be surmised that cardiac diseases that cause myocyte
decoupling should facilitate the emergence EADs when the repo-
larization reserve is reduced. A number of factors reduce cellular
coupling in diseased heart, including gap junction remodeling
and fibrosis. Fibrosis forms insulating barriers between cells and
group of cells by interstitial tissue deposits of collagenous fil-
aments by the proliferating cardiac myofibroblasts (Weber and
Brilla, 1991; Wynn, 2007). Aging in rats and rabbits is known
to manifest not only increased cardiac fibrosis but also down-
regulation of the gap junctional connexins43 (Cx43) (Sato et al.,
2009; Morita et al., 2011a) that effectively reduce the coupling
conductance between cardiac myocytes.
ROLE OF FIBROSIS
Traditionally, increased arrhythmic risk due to increased car-
diac fibrosis has been attributed to alteration in conduction and
reentry. The early seminal studies by Spach and associates have
shown that fibrotic changes in cardiac tissue that emerge in aged
hearts, reduces the safety margin for conduction by promoting
conduction block and reentry when the availability of the fast
sodium current (“source”) was reduced by premature electrical
stimulation (Spach et al., 1989, 2007).
While the alterations of cardiac conduction and the associ-
ated reentrant arrhythmias in a fibrotic cardiac tissue are well-
recognized both in animal (Spach, 1991; Hayashi et al., 2002,
2003) and human studies, (de Bakker et al., 1988; Wu et al.,
1998) the influence of cardiac tissue fibrosis on the genesis of
EADs during oxidative stress remained poorly explored. In view
of the discrepancy between the ability of oxidative stress to
induce EADs in isolated myocytes, but not in intact hearts from
young rats or rabbits, we hypothesized that cardiac tissue fibro-
sis would facilitate the generation of EADs and triggered activity
in intact hearts exposed to oxidative stress by altering source-sink
relationships. Since aged hearts exhibit increased fibrosis, we eval-
uated the influence of H2O2 and ATII to promote EAD-mediated
arrhythmias in isolated Langendorff-perfused hearts from aged
rat (∼2 years old) and middle aged rabbit (∼5–6 years old)
hearts, using high resolution optical mapping for cardiac acti-
vation pattern and glass microelectrode cellular recordings from
selected left ventricular (LV) epicardial sites. Aging-related fibro-
sis is apparent in these two species and manifested high degree
of heterogeneity in its distribution being very dense in the endo-
cardium with intermediate levels fibrosis on the anterior and pos-
terior LV wall as shown in Figure 3. In sharp contrast to adult nor-
mal hearts, the aged hearts of both species when exposed to oxida-
tive stress with H2O2 or ATII readily promoted EADs and trig-
gered activity that led to VT and then to VF (Morita et al., 2009,
2011b; Bapat et al., 2012). Figure 4 illustrates an episode of EAD-
mediated triggered activity in a middle-aged rabbit heart causing
a focal VT which then degenerates to VF. The focal VT caused by
EAD-mediated triggered activity originated from the base of the
heart, which then underwent functional conduction block due to
the emergence of spatially discordant APD alternans. Similarly,
in the aged fibrotic rat hearts oxidative stress with H2O2 pro-
moted EADs leading to triggered activity, VT and VF. In addition
to fibrosis, both species showed down-regulation of total Cx43 as
indicated by reduced distribution of detectable Cx43 immunos-
taining positive spots in the LV tissue (Morita et al., 2011b).
It could be argued that the observed differences between
the two age groups may result from aging-related ventricular
myocyte electrical remodeling whereby the sensitivity of the aged
cardiomyocyte to oxidative stress greatly increases relative to
young/adult cardiomyocytes (Anyukhovsky et al., 2002; Sudhir
et al., 2011). To investigate this possibility, we directly compared
the susceptibility of isolated single rat ventricular myocytes iso-
lated by enzymatic dissociation from young and aged rats and
subjected them to oxidative stress and studied them under patch-
clamp conditions. We exposed isolated ventricular myocytes from
both age groups to three different clinically-relevant stressors,
namely ATII, (Zhao et al., 2011) hypokalemia, (Osadchii, 2010),
and H2O2 (Nguyen et al., 2012). Our results show that both
young and aged isolated myocytes responded similarly to these
three stressors and readily induced EADs and triggered activ-
ity. These findings suggest that electrical remodeling is not a
major cause for the observed age-dependent differences to stress-
induced EADs, triggered activity and VT/VF at the whole heart
level. Figure 5 illustrates an example.
POTENTIAL ARRHYTHMOGENIC INFLUENCES OF
MYOCYTE-MYOFIBROBLAST COUPLING
Normal adult hearts contain more non-myocytes than myocytes,
with fibroblasts making up the majority of non-myocytes (Wynn,
2007; Kohl and Camelliti, 2012). Fibroblasts become activated by
injury and stress as part of a normal wound-healing response,
and differentiate into myofibroblasts which proliferate and secrete
collagen, smooth muscle α-actin, and stretch-sensitive ion chan-
nels, and connexins (Camelliti et al., 2004). Co-culture stud-
ies have shown that heterocellular coupling readily develops
between myocytes and myofibroblast via gap junction Cx43
molecules (Gaudesius et al., 2003; Miragoli et al., 2007; Jacquemet
and Henriquez, 2008; Vasquez et al., 2011). Since myofibrob-
lasts have a less negative resting membrane potential, they can
depolarize myocytes sufficiently to induce spontaneous pace-
maker activity when the myofibroblast population exceeds 15%
in co-cultures (Miragoli et al., 2007). While such heterocellular
couplings seen in tissue co-culture may play an active role in
arrhythmogenesis, at present definitive evidence that fibroblasts
or myofibroblasts form gap junctions with myocytes in intact
Frontiers in Physiology | Oxidant Physiology February 2013 | Volume 4 | Article 19 | 6
Karagueuzian et al. Oxidative stress, fibrosis, and arrhythmias
FIGURE 3 | Masson trichrome staining in adult and aged rat and
middle-aged rabbit ventricles. Notice increased fibrosis in the aged
compared to adult LV (top figures) with almost complete fibrosis at the
endocardium (Endo) with intermediate fibrosis of the posterior left ventricle
(LV) and the septum (blue color). Lower panels show LV fibrosis in the middle
aged compared to adult rabbit LV. Ant, anterior; RV, right ventricle; Post,
posterior; Epi, epicardium [from Sato et al., 2009 and Morita et al., 2009
(Lokuta et al., 2005)].
native heart tissues remains controversial. While awaiting a final
verdict to this important question, investigations as to how
myocyte to myofibroblast (M-MF) coupling may alter myocyte
electrophysiology remain of considerable interest in cardiac
arrhythmogenesis.
We investigated the influence ofM-MF coupling on the genesis
of EADs under conditions of reduced repolarization reserve using
the dynamic clamp technique to electronically couple an isolated
ventricular myocytes to a virtual “myofibroblast” endowed with
physiologically realistic membrane capacitance, resistance, volt-
age and gap junctional coupling resistance (MacCannell et al.,
2007). With this technique we sought to systematically define
the characteristics and the mechanisms by which the coupled
fibroblasts influence susceptibility to EADs.We found that M-MF
coupling promotes an Ito-like outward current in the cardiac
myocyte (Nguyen et al., 2012). The Ito-like current reflects the
chargemovement required to depolarize the fibroblastmembrane
capacitance from the coupled resting potential to the AP plateau.
This Ito-like current promotes EADs by lowering the AP plateau
voltage into the ICa-L window current range (Nguyen et al., 2012).
Not only does this allow ICa-L to reactivate, but it also slows the
activation of IKs by depressing the plateau voltage. Figure 6 illus-
trates this facilitative role of M-MF coupling in the induction of
EADs. The importance of the Ito-like current in the genesis of
EAD is clearly demonstrated by the suppression of the EADswhen
the Ito-like component was eliminated by the dynamic clamp
protocol (Nguyen et al., 2012; Workman et al., 2012). It should
be noted that Ito can also suppress EADs when its amplitude
or pedestal current becomes sufficiently large to overcome ICa-L
reactivation (Workman et al., 2012).
M-MF COUPLING AND EAD PROPAGATION IN 2D SIMULATED CARDIAC
TISSUE
Given the extreme heterogeneity of myocardial tissue fibrosis, we
investigated the importance of the level of fibrosis on initiation
and propagation of EADs. The level of fibrosis in our model was
graded by the number of fibroblasts that couple to a single car-
diomyocyte under conditions of reduced repolarization reserve
so to mimic oxidative stress. We found a critical level of fibrosis
(i.e., number of myofibroblast coupled to myocytes) was needed
to promote propagated EADs. That is either too few or too many
number of coupled fibroblasts prevented the genesis (too few) or
propagation (too many) of the EADs. A “critical” level of fibrosis
was needed for both initiation and the propagation of the EAD to
cause arrhythmias (Morita et al., 2009). Figure 7 illustrates this
phenomenon.
EADs, FIBROSIS, AND VT/VF IN HUMANS
Perhaps the first experimental study linking persistent INa-L to
EADs was made with the use of sea Anemonia sulcata toxin II
(ATX II) (Isenberg and Ravens, 1984). This early experimental
observation did not remain an isolated laboratory curiosity as it
was later discovered that a congenital form of a long QT syndrome
(LQTS) in humans, LQT3, is associated with a persistent INa-L
causing APD prolongation (Bennett et al., 1995) and a propensity
for TdP, VT, and VF (Moreno and Clancy, 2012). The presence
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FIGURE 4 | Spontaneous initiation of EAD-mediated VF in a middle-aged
rabbit exposed to 0.1mM H2O2. Panel (A) shows 6 simultaneously
epicardial optical APs (V1 to V6) recorded from the sites shown on the left
silhouette of the heart. After nine EAD-mediated focal activations arising from
the base of the heart (panel B) the wavefront undergoes block at mid LV
anterior wall (beat #10) after the emergence of a spatially discordant APD
alternans shown in panel (A) (L and S stand for short APD respectively). The
wavefront however, continues to propagate lateral to the site of block in a
clockwise direction causing the formation of a reentrant wave of excitation as
shown in the snap shots of beat #11 in panel (B). The red color in the snap
shots represents depolarization and the blue repolarization. The yellow
arrows in the snap shots represent the direction of the wavefront
propagation with double horizontal lines denoting the site of conduction
block. The numbers under each snap shot is activation time starting with
arbitrary zero ms for beast #3 and #4 and then again for beats #10 and #11.
Panel (C) is a microelectrode recording of another VF episode recorded in the
same heart showing spontaneous initiation of VF by a mechanism compatible
with EAD-mediated TA (from Sato et al., 2009).
of IN-La during the plateau phase of the AP can critically reduce
repolarization reserve despite its small magnitude (range 20–
60 pA), and coincides in time with the reactivation kinetics of
ICa-L(Madhvani et al., 2011) to promote EADs (Xie et al., 2009).
It is suggested that EADs caused by human cardiomyocytes lead
to triggered activity causing PVT and TdP, (Ruan et al., 2009)
the primary arrhythmia mechanism and cause of sudden cardiac
death in LQT3 carriers (Clancy and Kass, 2005). In addition to
congenital LQT3, ventricular myocytes isolated from human end-
stage failing hearts manifest EADs during adrenergic stimulation,
unlike non-failing myocytes (Veldkamp et al., 2001).
While cardiac diseased conditions are often associated with
pro-oxidant state and reduced repolarization reserve that could
promote EAD-mediated VT/VF, recent clinical studies provide
mounting evidence that increased cardiac fibrosis may also be
an independent predictor of VT/VF in humans (Klem et al.,
2012; Leyva et al., 2012). In our animal models of EAD-mediated
VT/VF, a simultaneous reduction in repolarization reserve and
a critical increase in cardiac fibrosis are necessary to promote
VT/VF. Evidence is mounting that human hearts also require a
similar “two-hit” scenario (reduced repolarization reserve and
fibrosis) to initiate VT/VF. Quantitative measurement of car-
diac fibrosis inhuman poses a great challenge. Early studies
relied on myocardial biopsy samples to assess the presence and
quantify myocardial fibrosis, clearly an inadequate approach to
assess global cardiac fibrosis. Since the demonstration of the late
gadolinium enhancement in cardiovascular magnetic resonance
imaging in patients with non-ischemic dilated cardiomyopathy
(DCM) to be similar to the cardiac fibrosis determined by histo-
logical examination at autopsy, (McCrohon et al., 2003) attempts
have been made to quantify global fibrosis in patients with DCM
using enhancement as a surrogate of fibrosis. The results of
these early studies showed that the extent of myocardial fibrosis
was an independent predictor for VT/VF in patients with DCM
(O’Hanlon et al., 2010) and a critical level of fibrosis was found
necessary to be predictive of sudden cardiac death and the num-
ber of ICD discharges in these patients (Klem et al., 2012; Leyva
et al., 2012). The fibrosis predictive ability of the occurrences of
sudden cardiac death and ICD discharges reaches a plateau at
scar sizes between 5% and 20% of the LV volume, with larger
fibrosis sizes tending to decrease the incidence of sudden cardiac
death and ICD discharges (Klem et al., 2012). This observation is
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FIGURE 5 | Angiotensin II induces EADs both in young/adult (A) and
aged (B) isolated LV myocytes. Effects of ATII (2μmol/L) in both age
groups are shown at two different pacing cycle lengths (PCLs). Both
young and aged myocytes manifested EADs and triggered activity with
significant differences between the two aged groups (from Bapat et al.,
2012).
FIGURE 6 | Promotion of EADs by myofibroblast-myocyte coupling
(M-F) during oxidative stress. Coupling a patch-clamped myocyte
superfused with normal Tyrode’s solution to a virtual fibroblast promotes
no EADs (A). However, coupling lowers the AP plateau and shortens
APD as shown in the superimposed traces at a faster time scale in panel
(B). Panel (C) (top traces) shows lack of EAD induction with 0.1mmol/L
H2O2 in the uncoupled state. However, coupling the myocyte to a virtual
fibroblast (Cf 6.3 pF, Gj 3.0 nS) caused EADs to reappear, which were
more prominent when Ef was −25mV (bottom traces) than −50mV
(middle traces). Cf is fibroblast capacitance in pF, Gj is M-F gap junctional
conductance in nS, and Ef is the resting potential of the fibroblast inmV
(from Nguyen et al., 2012).
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FIGURE 7 | 2D simulations in a tissue with progressive regional
increase in the number of fibroblasts to myocyte gap junction
couplings. Panels (A–C) are voltage snap shots after a paced beat from
the left border of the tissue (red) with central ellipse (site 2) representing
the region of progressive increase in fibroblast to myocyte (F-M) coupling
ratio. In panel (A) with F-M ratio of 1, promotes small amplitude
non-propagating EADs. Similar dynamic scenario is also observed when
the F-M ratio in the ellipse is raised to 3 as shown in panel (C). After the
paced beat, EADs die out locally under these two conditions of M-F
coupling. However, when the F-M ratio is in the intermediate range
(1.1, panel B) the EADs and triggered beats are now of higher amplitude
that propagate and excite the adjacent cardiac tissue as triggered beats.
The numbers on top of each snap show denote time in seconds after
the onset of paced beat from the left of the tissue. White arrows
indicate the direction of wavefront propagation [From Morita et al.,
2011a,b (Goldhaber, 1996)].
compatible with our experimental (Morita et al., 2009) and 2D
simulation studies where we show the need for a critical level
of fibrosis to promote propagated EADs (Figure 7). These early
studies suggest that fibrosis could be used as a marker for risk
stratification of sudden cardiac death, (Sovari and Karagueuzian,
2011; Klem et al., 2012; Leyva et al., 2012) and that imaging car-
diac fibrosis with enhancement appears to more accurately reflect
the presence and extent of cardiac fibrosis than ejection frac-
tion. For example, patients with DCM and fibrosis s may have
preserved ejection fraction (Biagini et al., 2012) and conversely
others without myocardial scarring and fibrosis manifest severely
reduced ejection fraction because of intrinsic depression of car-
diac muscle contractility. Figure 8 illustrates schematically our
current understanding of the mechanisms involved in oxidative
stress-mediated EAD in promoting VT/VF.
ANTIFIBROTIC AND ANTIARRHYTHMIC DRUG THERAPY IN HUMAN
VT/VF
Therapy for the management of EAD-mediated VT/VF in fibrotic
hearts can be targeted either to critically increase repolariza-
tion reserve and/or decrease cardiac fibrosis. At present, selective
antiarrhythmic drugs that specifically target the kinetics of
activation and inactivation of ICa-L and outward potassium cur-
rents without affecting excitation-contraction coupling are still
lacking. It is becoming increasingly evident that targeting the
therapy against cardiac fibrosis may be a viable alternative to pre-
vent VT/VF. While data on the efficacy of antifibrotic therapy
against VT/VF in humans is sparse, indirect clinical and direct
experimental findings suggest the possibility that reduction of
myocardial tissue fibrosis reduces the recurrences of VT/VF.
Antifibrotic therapy may be targeted against elevated and dis-
proportionate collagen accumulation or against myofibroblast
proliferation or both. The study by Lopez et al. showed that
torsemide, a loop diuretic, reduces ventricular collagen volume
fraction (CVF) in patients with chronic heart failure (Lopez et al.,
2007). Torsemide inhibits the enzyme involved in myocardial
extracellular generation of collagen type I molecules (i.e., procol-
lagen type I carboxy-terminal proteinase or PCP) thus reducing
myocardial CVF assessed in right septal endocardial biopsies from
patients with chronic heart failure (Lopez et al., 2007). Once
fibrosis emerges in the heart its speed of expansion is a rela-
tively fast phenomenon and therefore antifibrotic measures need
to start sooner rather than later. A recent study in patients with
hypertrophic cardiomyopathy (HCM), fibrosis was assessed by
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FIGURE 8 | Flow chart showing oxidative stress signaling pathways
for H2O2 (panel A) and ATII (panel B) in isolated ventricular
myocytes and whole normal and fibrotic hearts. While EADs are
readily induced by the proposed oxidative signaling pathways in the
isolated ventricular myocytes, the initiation of EADs and VT/VF in the
whole heart is restricted only to structurally remodeled heart with
increased fibrosis. Induction of fibrosis by either H2O2 or ATII promotes
EADs in isolated cardiac myocytes however, at the whole heart level only
the presence of enhanced cardiac fibrosis could lead to propagated EADs
by the mechanism of triggered activity leading to VT/VF. ASK1 is
apoptosis signaling kinase 1, is a member of mitogen-activated protein
kinase kinase kinase family that activates JNK (c-Jun N-terminal kinase)
and p38 kinase (p38 mitogen-activated kinase) eventually initiating
transcription causing hypertrophy and fibrosis.
gadolinium enhancement MRI at two time points separated by
about a 2 years period. It was found that the enhancement incre-
ment was a relatively fast event and was directly related to the
worsening of the clinical outcome of the patients (Todiere et al.,
2012). During a median follow-up of 24 months a sharp step-up
of SCD and ICD discharges was observed for scar size>5% of the
LV mass (hazard ratio: 5.2; 95%; confidence interval: 2.0–13.3)
(Klem et al., 2012).
Potentially, there is a wide range of possible antifibrotic treat-
ment options in humans that could target the transforming
growth factor-β1 (TGF-β1), endothelin-1 (ET-1), connective tis-
sue growth factor (CTGF), ATII, and platelet-derived growth
factor (PDGF) networks (Leask, 2010). Much of these interven-
tions have been tested in animal models with various degrees
of success. TGF-β1 is a well-recognized mediator of tissue heal-
ing and a major fibrosis-inducing cytokine that contributes to
multiple fibroproliferative disorders, including cardiac fibrosis
associated with heart failure. It is locally generated in most cell
types, and several studies have shown beneficial value against the
pathological development of fibrosis with suppression of TGF-
β1 activity. In response to ATII, TGFβ1 expression is increased,
converts fibroblasts into myofibroblasts, and generates extracel-
lular matrix proteins such as type I collagen (Leask, 2007). For
example, drugs that inhibit the renin–angiotensin–aldosterone
system (RAAS) suppress cardiac fibrosis via improved hemody-
namics and directly through inhibition of myofibroblast activity
and collagen synthesis. Eplerenone, an ATII receptor blocker,
greatly reduced cardiac fibrosis and arrhythmias inducibility
in aged mice (Stein et al., 2010). In humans, RAAS activa-
tion increases ATII level, which is pro-arrhythmogenic, while
RAAS inhibition reduces the arrhythmic risk, (Yusuf et al.,
2000; Teo et al., 2004) likely by reduction of cardiac fibrosis as
shown in animal studies. Recently, reduction of the glycopro-
tein endoglin, a co-receptor of TGFβ1 signaling in the cardiac
fibroblast, correlates with an attenuation of cardiac fibrosis in
patients with heart failure (Kapur et al., 2012). In these studies,
an association between levels of endoglin, which are significantly
increased in individuals with severe LV failure before implanta-
tion of the LV assist device (LVAD) but are dramatically reversed
back to control levels in a separate cohort after LVAD place-
ment. Because no direct assessment of the level of cardiac tissue
fibrosis was done in this cohort, the clinical value of endoglin
reduction in limiting the expansion of cardiac tissue fibrosis in
humans is still to be determined (Benjamin, 2012). Similarly,
block of mineralocorticoid receptors or endothelin receptors,
(Mayyas et al., 2010) or block of TGF-beta synthesis with pir-
fenidone, (Lee et al., 2006; Nguyen et al., 2010) are shown to
reduce LV fibrosis, dysfunction and arrhythmias after myocardial
infarction in rats. These experimental findings are encourag-
ing and suggest that reduction of cardiac fibrosis is not only
possible, but also may reduce the risk of cardiac arrhythmias
(Li et al., 2001; Vermes et al., 2003; Zeisberg et al., 2007; Ago
et al., 2010; Leask, 2010; Massare et al., 2010; Tyralla et al.,
2011).
CONCLUSIONS
It is hoped that the basic research findings will be translated into
clinical strategies to reduce cardiac arrhythmia risk in patients
with heart disease. Antifibrotic therapy seems to hold great
promise, as the independent role of fibrosis in the genesis of
VT/VF is becoming increasingly recognized. Drugs directly tar-
geting EAD formation may also be identified, now that the
dynamical mechanisms involved have been clearer. For exam-
ple, given the key role of ICa-L reactivation, drugs that shift the
voltage dependence of steady-state activation and inactivation
to reduce the amplitude of ICa-L window currents could poten-
tially suppress EAD formation without adversely affecting normal
excitation-contraction coupling. Similarly, specific blocker of the
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late INa current can also be useful in suppressing EADs as block
of late Na channel openings does not interfere with excitation-
contraction coupling. Finally, interventions designed to sup-
press oxidative stress or inhibit CaMKII activation in the setting
chronic heart disease could also play a role.
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